PharmAust in strategic alliance to develop vaccine research

Diversified perth-based pharmaceutical group PharmAust Ltd and US company Pure Vaccine Solutions have entered into an exclusive global Strategic Alliance Agreement to provide immunological screening services and research into avian 'bird flu' vaccine.

The agreement will see PharmAust's wholly owned subsidiary, Mimotopes Pty Ltd,and Pure Vaccine Solutions cross-promote and market a full suite of products and services for vaccine development.

Mimotopes director of research Dr Nicholas Ede said the alliance would offer vaccine developers a unique platform to develop novel peptide based vaccines by bridging current screening gaps and considerably shortening the route to commercialisation.


(existing subscribers)

The password field is case sensitive.
Request new password

Register for free

Sign up here for free access to 8 articles per month + twice daily business email alerts.

Thanks! This question prevents spammers...
Enter the characters shown in the image.

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BN30 Index

Index = 100 as of 4 Jan 2016
Source: Morningstar

Total Shareholder Return as at 30/09/16

1 year TSR5 year TSR
105thFortescue Metals Group182%5%
453rdIluka Resources4%-10%
462ndWoodside Petroleum3%3%
729thAtlas Iron-64%-67%
774 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$0 Other
$0 Other
$0 Issued
Total value as at the date of the transaction
Source: Morningstar


1st-Fortescue Metals Group$9,806.1m
3rd-Woodside Petroleum$6,935.4m
4th↑Iluka Resources$884.1m
5th↑Atlas Iron$803.7m
519 listed resources companies ranked by revenue.
Source: Morningstar

Remuneration from Fortescue Metals Group

3rdNev Power$5.992m
13thStephen Pearce$2.551m
25thNick Cernotta$1.566m
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer